Neuroblastoma accounts for 6 percent of all cancers in children, and is deadly in kids under 5. Many times, the cancer spreads to the lymph nodes before parents even notice a lump. Now, a 4-year-old boy who fought the disease is helping other kids fight back.
SpinalCyte recently announced the issuance of new patents in the USA and Japan. The company’s patent portfolio now includes 39 US and international patents issued with over 100 patents pending focused on the clinical use of fibroblasts. The company received investigational new drug clearance from the US Food and Drug Administration in November 2018 to […]
SpinalCyte was issued new patents in the U.S. and Japan. Five things to know: 1. SpinalCyte is a regenerative medicine company focused on spinal disc regrowth using human dermal fibroblasts. 2. The company’s CybroCell product is the first off-the-shelf allogenic human dermal fibroblast product. It’s used indegenerative disc disease treatments. 3. The patents describe methods to differentiate […]